Background: Kawasaki disease (KD), a systemic vasculitis, is suspected to be related to abnormalities in innate immunity. Based on the important role of IL-1 signaling in innate immunity, we investigated the effects of an anti-IL-1β antibody using a Candida albicans water-soluble fraction (CAWS)-induced mouse model of KD.
Introduction
Kawasaki disease (KD), a systemic vasculitis of unknown etiology, is the most common cause of childhoodacquired heart disease in developed countries. Severe inflammation of the coronary arteries results in coronary sequelae such as coronary artery aneurysms and stenosis in about 3% of all patients with KD. Murata et al. re- ported that the alkaline component of Candida albicans in the stools of patients with KD causes systemic vasculitis 1 .
Ohno et al. reported that the C. albicans water-soluble fraction (CAWS) causes strong systemic vasculitis in the mouse aortic root 2, 3 . Resembling the phenotype of vasculitis in KD, CAWS-induced vasculitis is a major mouse model for studies of KD and has been used to investigate the mechanisms underlying vasculitis and potential treatments 4 6 .
KD is characterized by hypercytokinemia and suspected abnormalities of innate immunity at onset 7 . The inhibition of IL-1 signaling is an established strategy for preventing tissue damage and inflammation in innate im- Fig. 1 Experimental procedure KD-like vasculitis was induced by the peritoneal injection of CAWS (0.5 mg for five consecutive days) in 5-week-old male DBA/2 mice. The anti-mouse IL-1β antibody 01BSUR was administered to mice at various doses and various time points. For the evaluation of various doses, 01BSUR was administered at 2.5, 50, and 10.0 mg/kg on the second day after the initial CAWS injection (A). For the evaluation of 01BSUR various timings, 01BSUR at 10.0 mg/kg was administered 2 days before, the same day, 2 days after, 5 days after, 7 days after, and 14 days after the initial CAWS injection (B). mune diseases as well as autoimmune diseases 8 . Suppressing IL-1 signaling is expected to attenuate KDinduced vasculitis. It has been reported that an IL-1β receptor antagonist (Anakinra) inhibits vasculitis in another KD mouse model induced by components of the Lactobacillus casei cell wall extract 9, 10 . We investigated whether IL-1β signaling inhibition using an anti-IL-1β antibody suppresses vasculitis in the CAWS-induced mouse model of KD and examined the mechanism underlying the inhibitory effects on vasculitis.
Materials and Methods
The study was performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication number 85-23, revised 1996). The study protocol was approved by the Animal Care and Use Committee of Nippon Medical School .
Animals
Five-week-old male DBA/2 mice were purchased from Sankyo Labo Service Co., Ltd. (Tokyo, Japan). All mice were maintained under specific pathogen-free conditions according to the Guidelines for Animal Care of the National Institute of Infectious Diseases in Tokyo (NIID).
Water and food were available ad libitum.
CAWS and Anti-Murine IL-1β Antibody Preparation
CAWS was prepared from C. albicans strain NBRC1385
in accordance with a previously reported method 11 .
Briefly, 5 L of C-limiting medium was maintained in a glass incubator for 2 days at 27°C while air was supplied at a rate of 5 L/min and the mixture was swirled at 400 rpm. Following culture, an equal volume of ethanol was added. After allowing the mixture to stand overnight, the precipitate was collected. The precipitate was dissolved in 250 mL of distilled water, and ethanol was added. The mixture was then allowed to stand overnight. The precipitate was collected and dried with acetone to obtain
CAWS.
An anti-Murine IL-1β antibody (01BSUR) identified as a neutralizing antibody for mouse IL-1β 12, 13 , was provided by Novartis Pharma K.K. Co., Ltd. (Tokyo, Japan).
Induction of Vasculitis and Administration of 01

BSUR
As summarized in Figure 1 , CAWS (0.5 mg/mouse) was injected intra-peritoneally in 5-week-old DBA/2 mice on five consecutive days 4 . 01BSUR was administered to mice at various doses and at various time points.
Six mice were assigned to each group. As a control, in-stead of CAWS, mice were administered saline.
On the experiment at 01BSUR various doses, 01BSUR
was administered intraperitoneally at doses of 2.5, 5.0, and 10.0 mg/kg on the second day after CAWS administration started. On the experiment at 01BSUR various timing, 01BSUR at 10.0 mg/kg was injected 2 days before, on the same day, 2 days after, 5 days after, 7 days after, and 14 days after the administration of CAWS.
At 4 weeks, the mice were killed with an over-dose administration of pentobarbital. The blood and heart were obtained for subsequent analyses.
Histological Evaluation
The heart tissues were fixed in formalin and embedded in paraffin. Serial sections were made at a thickness of 4 μm and stained by hematoxylin and eosin (H&E). Sections showing both the aortic root and the most severe inflammatory cell invasion were used. The area (mm 2 ) of inflammatory cell infiltration was measured using the hybrid cell count system (KEYENCE) and KEYENCE BZ-X analyzer (Osaka, Japan). The ratio of the inflammatory area to the total tissue area on the aortic root was calculated.
Serologic Evaluation
Serum samples collected were stored at −20°C until 
Statistical Analysis
Data are expressed as means SD. ANOVA was used to analyze statistical differences among groups. When significance was detected, the Wilcoxon test was used as a post-hoc test to compare the two groups. A value of p < 0.05 was considered statistically significant.
Results
There was no incidence of death in the mice used for the analysis of various 01BUSR dosages. In the 01BSUR various timing study, one mouse died in the group injected with 01BUSR 2 days before the CAWS injection.
Histological Evaluation
In the analysis of the various 01BUSR dosages, the total inflammatory area was significantly lower in each 01 3A) .
In the analysis of the 01BUSR various timing study, the total inflammatory area for each group, i.e., CAWS, 2 days before, on the same day, 2 days after, 5 days after, 7
days after, and 14 days after CAWS administration, were The levels of IL-6 in the serum in the CAWS, 2 days before, same day, 2 days after, 5 days after, 7 days after, and 14 days after groups were 92.8 12.6 pg/mL, 29.4
12.8 pg/mL, 39.6 4.7 pg/mL, 31.4 9.1 pg/mL, 55.6 7.6 pg/mL, 38.6 15.2 pg/mL, and 30.0 6.6 pg/mL (Fig. 6B) . Compared with the CAWS group, IL-6 levels were significantly lower in all other groups (2 days before: p = 0.0149, same day: p = 0.0182, 2 days after: p = 0.0081, 7 days after: p = 0.0383, and 14 days after: p = 0.0082), except for the 5 day after group (p = 0.0538).
The levels of TNF-α in the serum in the CAWS, 2 days before, same day, 2 days after, 5 days after, 7 days after, and 14 days after groups were 244.4 34.3 pg/mL, 27.2 Fig. 3 Ratio of inflammatory area to total aortic root tissue area The inflammatory cell invasion area was evaluated by the hybrid cell count system (KEYENCE) using the KEYENCE BZ-X analyzer (Osaka, Japan). The inflammation area is expressed as a ratio with respect to the total tissue area of the aortic root. A: On the 01BSUR various dosage experiments inflammation was significantly attenuated from the low dose of 01BSUR. B: On the 01BSUR various timing experiment, inflammation was significantly attenuated in all groups, but not in the 14 days after group. The number of mice in each group was six, except for the 2 days before group (n=5). 64.4 pg/mL, respectively (Fig. 6C) . Compared with the CAWS group, TNF-α levels were significantly lower in Fig. 5 Cytokine profiles for various doses of 01BSUR A: IL-1β levels were not significantly different between groups, except between the 01BSUR 2.5 mg/kg group and the CAWS group. IL-1β in the 01BSUR 2.5 mg/kg group was significantly lower than that in the CAWS group (p = 0.0051). B: IL-6 levels were significantly lower in the control, 01BSUR 5 mg/kg, and 10 mg/kg groups. IL-1 tended to be lower in the 01BSUR 2.5 mg/kg group (p = 0.0656) than in the CWAS group. C: Compared to the CAWS group, TNF-α levels tended to be lower in each group. D: IL-10 levels were not significantly different between groups, other than the 01BSUR 5 mg/kg group (in which IL-10 was significantly lower than that in the CAWS group, p=0.0306). Control group: mice were injected with saline instead of CAWS. The number of mice in each group was six. the 2 days before group (p = 0.0058) and the same day group (p = 0.0034), but not in the other groups (2 days after group: p = 1.0000, 5 days after group: p = 0.0741, 7 days after group: p = 0.4320, and 14 days after group: p = 0.0538).
The levels of IL-10 in the serum in the CAWS, 2 days before, same day, 2 days after, 5 days after, 7 days after, and 14 days after groups were 100. IVIG attenuates KD vasculitis and lowers the rate of CAL occurrence. However, IVIG non-responders still account for about 20% of patients, and CAL formation is highly likely in this group 14 . Steroid therapy is used in addition to IVIG in high-risk cases where IVIG is not likely to be effective 15 . A combination of steroid and IVIG therapy reduces the IVIG non-responder rate as well as CAL occur- Fig. 6 Cytokine profiles for anti-mouse IL-1β antibody (01BSUR) at various times of injection A: IL-1β levels were significantly lower in groups injected with 01BSUR 2 days before (p = 0.0053), the same day (p = 0.0025), 7 days after (p = 0.0378), and 14 days after (p = 0.0099) CAWS administration. B: IL-6 was significantly lower in each group (2 days before: p = 0.0149, the same day: p = 0.0182, 2 days after: p = 0.0081, 7 days after: p = 0.0383, and 14 days after: p = 0.0082) compared to the CAWS group, except for the group injected with 01BSUR 5 days after CAWS administration. C: TNF-α levels were significantly lower in groups injected with 01BSUR 2 days before (p = 0.0058) and the same day (p = 0.0034) as CAWS administration compared to the CAWS group. D: IL-10 levels were significantly lower in groups injected with 01BSUR 2 days before (p = 0.0042), the same day (p = 0.0021), and 14 days after (p = 0.0153) CAWS administration compared to the CAWS group. IL-10 levels tended to be elevated in the group injected with 01BSUR 5 days after CAWS administration. The number of mice in each group was six, except for the 2 days before group (n=5). rence 15 . Infliximab, a monoclonal antibody against human TNFα, is a potential strategy for refractory KD. A randomized trial of infliximab for initial IVIG nonresponders showed a significantly greater defervescence rate as compared to that for repeated IVIG 16 . However, the rate was 76.7% and there were still non-responders. reported that CBA/J mice produce high levels of immunosuppressive IL-10 and are resistant to CAWS vasculitis 26 . Additionally, IL-10 depletion facilitates inflammation via IL-1β activity in both mice and humans 27 . We hypothesize that IL-1β inhibition by 01BSUR may restore IL-10, which attenuates vasculitis, even after CAWS administration when TNFα levels are already elevated. Further studies are necessary to evaluate this hypothesis. 
Conclusion
